Concepts (52)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospital Units | 1 | 2020 | 30 | 0.730 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 25 | 0.720 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 54 | 0.710 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 79 | 0.700 |
Why?
|
| Computed Tomography Angiography | 2 | 2021 | 146 | 0.700 |
Why?
|
| Radiography, Interventional | 1 | 2020 | 154 | 0.670 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2023 | 154 | 0.370 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2024 | 142 | 0.270 |
Why?
|
| X-linked Nuclear Protein | 1 | 2024 | 9 | 0.240 |
Why?
|
| Co-Repressor Proteins | 1 | 2024 | 24 | 0.240 |
Why?
|
| Receptors, Peptide | 1 | 2024 | 22 | 0.240 |
Why?
|
| Intestinal Neoplasms | 1 | 2024 | 64 | 0.230 |
Why?
|
| Molecular Chaperones | 1 | 2024 | 122 | 0.230 |
Why?
|
| Neuroendocrine Tumors | 1 | 2024 | 118 | 0.210 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2021 | 20 | 0.200 |
Why?
|
| Stomach Neoplasms | 1 | 2024 | 282 | 0.190 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 665 | 0.180 |
Why?
|
| Angiography | 1 | 2021 | 208 | 0.180 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 59 | 0.180 |
Why?
|
| Fluoroscopy | 1 | 2020 | 123 | 0.180 |
Why?
|
| Workflow | 1 | 2020 | 80 | 0.180 |
Why?
|
| Workload | 1 | 2020 | 129 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 1 | 2024 | 669 | 0.160 |
Why?
|
| Neuroblastoma | 1 | 2021 | 395 | 0.150 |
Why?
|
| Medicare | 1 | 2021 | 425 | 0.150 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 1120 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2024 | 9057 | 0.110 |
Why?
|
| Mutation | 1 | 2024 | 4143 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 2362 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2023 | 192 | 0.090 |
Why?
|
| Humans | 7 | 2024 | 89349 | 0.070 |
Why?
|
| Prognosis | 2 | 2024 | 3783 | 0.070 |
Why?
|
| Octreotide | 1 | 2024 | 23 | 0.060 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2024 | 93 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 6811 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 337 | 0.050 |
Why?
|
| Tumor Burden | 1 | 2023 | 308 | 0.050 |
Why?
|
| Aged | 3 | 2024 | 19165 | 0.050 |
Why?
|
| Histiocytes | 1 | 2021 | 22 | 0.050 |
Why?
|
| Research Report | 1 | 2021 | 44 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2021 | 221 | 0.050 |
Why?
|
| Antigens, CD19 | 1 | 2021 | 42 | 0.050 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2021 | 51 | 0.050 |
Why?
|
| Radiology, Interventional | 1 | 2021 | 69 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1365 | 0.040 |
Why?
|
| Middle Aged | 2 | 2024 | 25974 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1224 | 0.030 |
Why?
|
| Male | 2 | 2024 | 42410 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 2566 | 0.020 |
Why?
|
| Female | 2 | 2024 | 46200 | 0.020 |
Why?
|
| United States | 1 | 2021 | 6987 | 0.020 |
Why?
|
| Adult | 1 | 2024 | 26607 | 0.020 |
Why?
|